Alexander T Cohen Selected Research

Frailty

11/2018

Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander T Cohen Research Topics

Disease

116	Venous Thromboembolism 05/2024 - 03/2002
90	Hemorrhage 05/2024 - 08/2004
39	Neoplasms (Cancer) 05/2024 - 03/2002
31	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 11/2002
27	Pulmonary Embolism 01/2022 - 01/2005
20	Thrombosis (Thrombus) 04/2023 - 03/2002
11	Stroke (Strokes) 05/2024 - 03/2009
6	Atrial Fibrillation 05/2024 - 01/2018
5	Body Weight (Weight, Body) 08/2021 - 09/2016
4	Obesity 08/2021 - 02/2005
4	Thromboembolism 11/2016 - 01/2005
3	Ischemic Stroke 05/2024 - 05/2014
3	Heart Failure 11/2017 - 06/2003
3	Myocardial Infarction 05/2014 - 07/2009
2	Hematoma 05/2024 - 01/2021
2	Cerebral Hemorrhage 05/2024 - 01/2021
2	Wounds and Injuries (Trauma) 09/2023 - 01/2020
2	Urogenital Neoplasms 01/2023 - 10/2022
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 09/2021
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 01/2019
2	Embolism (Embolus) 10/2022 - 05/2015
2	Chronic Renal Insufficiency 06/2022 - 01/2022
2	Inflammation (Inflammations) 01/2019 - 01/2017
2	Renal Insufficiency (Renal Failure) 01/2019 - 03/2017
2	Varicose Veins (Varicose Vein) 04/2016 - 02/2005
2	Infections 04/2012 - 06/2003
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2010 - 07/2009
1	Rare Diseases (Rare Disease) 05/2024
1	Neurologic Manifestations (Neurological Manifestations) 05/2024
1	Neoplasm Metastasis (Metastasis) 09/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023
1	Melanoma (Melanoma, Malignant) 09/2023
1	Leukemia 07/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2022
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2022
1	Phlebitis 01/2022
1	Hepatic Infarction 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Thrombocytopenia (Thrombopenia) 08/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2021
1	Thrombotic Microangiopathies 08/2021
1	Liver Diseases (Liver Disease) 01/2020

Drug/Important Bio-Agent (IBA)

56	AnticoagulantsIBA 04/2024 - 01/2006
38	Enoxaparin (Lovenox)FDA LinkGeneric 11/2023 - 03/2002
33	RivaroxabanIBA 05/2024 - 06/2012
33	apixabanIBA 01/2024 - 02/2014
30	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2024 - 11/2002
27	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 11/2002
21	betrixabanIBA 02/2023 - 03/2014
19	Vitamin K FDA Link 07/2020 - 07/2010
18	edoxabanIBA 01/2024 - 09/2010
13	Factor Xa InhibitorsIBA 05/2024 - 01/2016
13	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 02/2008
10	fibrin fragment D (D-dimer)IBA 02/2023 - 05/2004
8	Dalteparin (Dalteparin Sodium)FDA Link 01/2024 - 08/2004
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 01/2006
6	PRT064445IBA 05/2024 - 01/2016
5	Factor Xa (Coagulation Factor Xa)IBA 10/2023 - 01/2016
5	Dabigatran FDA Link 07/2020 - 06/2012
5	Fondaparinux (Arixtra)FDA Link 06/2020 - 02/2006
3	Hemostatics (Antihemorrhagics)IBA 05/2024 - 01/2019
3	CreatinineIBA 01/2023 - 09/2016
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 09/2016
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2015
3	ORALIT (ORS)IBA 01/2018 - 10/2017
3	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 09/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2017 - 09/2016
3	ximelagatran (Exanta)IBA 01/2006 - 02/2003
3	melagatranIBA 01/2006 - 02/2003
2	AlbuminsIBA 02/2023 - 01/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2006
2	C-Reactive ProteinIBA 01/2019 - 11/2017
2	A-factor (Streptomyces)IBA 01/2019 - 01/2016
2	cupric sulfide (CuS)IBA 12/2018 - 01/2018
2	AntithrombinsIBA 01/2006 - 02/2003
2	enoxaparin sodium FDA LinkGeneric 01/2005 - 05/2004
1	eculizumab FDA Link 05/2024
1	AntidotesIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Prothrombin (Factor II)IBA 04/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	2- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)IBA 01/2022
1	VaccinesIBA 08/2021
1	COVID-19 VaccinesIBA 08/2021
1	Antineoplastic Agents (Antineoplastics)IBA 05/2020

Therapy/Procedure

40	Therapeutics 05/2024 - 07/2010
6	Secondary Prevention 12/2019 - 03/2009
4	Drug Therapy (Chemotherapy) 09/2021 - 02/2011
4	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2010 - 11/2002
3	Length of Stay 01/2023 - 12/2015
2	Duration of Therapy 09/2023 - 03/2014
2	Bridge Therapy 01/2020 - 11/2018
2	Operative Surgical Procedures 01/2020 - 02/2011
2	Orthopedic Procedures 01/2006 - 11/2002
1	Minor Surgical Procedures (Minor Surgery) 09/2023
1	Palliative Care (Palliative Therapy) 01/2023
1	Catheters 12/2021
1	Oral Administration 02/2021
1	Time-to-Treatment 01/2021
1	Anticoagulation Reversal 01/2021